Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
J B Chemicals & Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:506943NSE Symbol: JBCHEPHARMP/E(TTM):38.68
ISIN Demat:INE572A01036Div & Yield %:0.78EPS(TTM):40.38
Book Value(Rs):202.8086013Market Cap ( Cr.):24315.22Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :      
Sales Turnover 3298.642884.162189.881892.001640.741501.19
Excise Duty0.000.000.000.000.000.00
Net Sales3298.642884.162189.881892.001640.741501.19
Other Income 34.678.6538.61115.9247.1336.53
Stock Adjustments 49.2227.4825.5715.70-2.5321.66
Total Income3382.532920.292254.062023.621685.341559.38
EXPENDITURE :      
Raw Materials 1158.291064.21769.27641.46566.61558.02
Power & Fuel Cost87.9591.4471.3762.6061.5463.29
Employee Cost 565.38499.95399.06305.98293.78257.98
Other Manufacturing Expenses 120.93106.1397.3684.6977.0682.52
Selling and Administration Expenses 446.93394.90305.91204.68205.02212.12
Miscellaneous Expenses 88.9690.3363.5855.9673.7556.79
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure2468.442246.951706.541355.371277.771230.71
Operating Profit914.09673.34547.52668.25407.59328.67
Interest 40.5234.314.957.192.944.57
Gross Profit873.57639.03542.57661.06404.65324.10
Depreciation135.24111.9971.2867.3665.0954.82
Profit Before Tax738.33527.04471.29593.70339.56269.28
Tax145.4983.35122.50137.5082.0275.92
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax49.4954.80-12.219.12-10.6011.30
Reported Net Profit543.36388.89361.00447.08268.14182.06
Extraordinary Items 11.702.9227.7546.9712.6212.09
Adjusted Net Profit531.66385.97333.25400.11255.52169.97
Adjst. below Net Profit -3.710.130.07-12.50-5.060.00
P & L Balance brought forward2070.161808.731575.181214.011092.46935.69
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 156.99127.59127.5273.42141.5320.15
P & L Balance carried down2452.822070.161808.731575.181214.011097.60
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %1225.00887.50825.00825.00550.00250.00
Earnings Per Share-Unit Curr35.0150.2646.7157.8534.7022.69
Earnings Per Share(Adj)-Unit Curr35.0125.1323.3628.9317.3511.35
Book Value-Unit Curr185.98315.65272.21233.75187.02185.02